In Focus Podcast | Can India make cancer care more affordable?

By The Hindu

Community Score: 50% | 968 views | 1w

0 community ratings: null thumbs up, null thumbs down

The Supreme Court has called out the rampant profiteering in the healthcare sector, including cancer medication. Terming the overpricing of essential cancer medicines as “broad, daylight dacoity”, the court said, “This is carnage. Plain and simple. The cancer drug is priced at an MRP of Rs 27,000 despite being supplied to retailers for Rs 2,700.” Ten times higher markup! It also suggested capping the profit margin for all medicines at 16%. India’s cancer burden is growing at an alarming rate. Every year, we record 15.6 lakh new cancer cases, and 9 lakh deaths due to cancer. More than 90% of India’s working population doesn’t have a stable or formal employment. A majority of them are not adequately covered by health insurance. Taken together, this means high out of pocket expenditure for treatment, which imposes a huge economic burden on the patient’s family. A recent survey showed that the overall prevalence of Catastrophic Health Expenditure (CHE) was 80.4% due to outpatient treatme

Tags: the hindu, the hindu news, the hindu latest news, cancer treatment India, cancer medicines India, cancer drug prices, healthcare costs India, Supreme Court India, cancer care India, healthcare profiteering, medicine prices India, out of pocket healthcare, catastrophic health expenditure, cancer patients India, affordable cancer care, drug pricing India, pooled procurement, value based pricing, generic medicines, off patent drugs